pyrazole and sr141716

pyrazole has been researched along with sr141716 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kruse, CG; Lange, JH1
Chang, CP; Chao, YS; Chiu, HH; Chu, CM; Chung, WL; Hsieh, WP; Hung, MS; Kuo, CW; Lin, Y; Shia, KS; Song, JS; Tai, CL; Tseng, SL; Tung, YS; Wu, CH1
Chao, YS; Chiu, HH; Chu, CM; Hsieh, MT; Hung, MS; Kuo, CW; Shia, KS; Song, JS; Suja, TD1
Baset, MA; El-Eraky, WI; Fahmy, HH; Khalifa, NM; Nossier, ES1
Brimble, MA; Furkert, DP; Glass, M; Govindpani, K; Grant, PS; Hunter, M; Kahlcke, N; MacDonald, C1

Other Studies

5 other study(ies) available for pyrazole and sr141716

ArticleYear
Cannabinoid CB1 receptor antagonists in therapeutic and structural perspectives.
    Chemical record (New York, N.Y.), 2008, Volume: 8, Issue:3

    Topics: Animals; Anti-Obesity Agents; CHO Cells; Cricetinae; Cricetulus; Humans; Imidazoles; Isomerism; Models, Chemical; Obesity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Solubility; Structure-Activity Relationship; Thiazoles; Triazoles; Water

2008
Bioisosteric replacement of the pyrazole 5-aryl moiety of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A). A novel series of alkynylthiophenes as potent and selective cannabinoid-1 receptor antag
    Journal of medicinal chemistry, 2008, Sep-11, Volume: 51, Issue:17

    Topics: Animals; Binding Sites; Hydrophobic and Hydrophilic Interactions; Mice; Mice, Obese; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Structure-Activity Relationship; Thiophenes; Weight Loss

2008
Bioisosteric replacement of the pyrazole 3-carboxamide moiety of rimonabant. A novel series of oxadiazoles as CB1 cannabinoid receptor antagonists.
    Organic & biomolecular chemistry, 2008, Sep-21, Volume: 6, Issue:18

    Topics: Amides; Cell Line; Humans; Isomerism; Molecular Structure; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Structure-Activity Relationship

2008
Design and Synthesis of Novel Pyrazole-Substituted Different Nitrogenous Heterocyclic Ring Systems as Potential Anti-Inflammatory Agents.
    Molecules (Basel, Switzerland), 2017, Mar-24, Volume: 22, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Celecoxib; Cyclooxygenase Inhibitors; Drug Design; Edema; Heterocyclic Compounds; Injections; Male; Molecular Docking Simulation; Piperidines; Pyrazoles; Rats; Rimonabant

2017
Divalent cannabinoid-1 receptor ligands: A linker attachment point survey of SR141716A for development of high-affinity CB1R molecular probes.
    Bioorganic & medicinal chemistry letters, 2019, 11-01, Volume: 29, Issue:21

    Topics: Allosteric Site; Binding, Competitive; Cannabinoids; Ligands; Molecular Probes; Molecular Structure; Protein Binding; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Structure-Activity Relationship

2019